🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Harnal-D Tab.

Found 11 matching trials

Advanced Benefits of Alpha-blocker Monotherapy on Lower Urinary Tracts Symptoms(LUTS) Patients

PHASE4

The purpose of this study is to evaluate the clinical efficacy of alpha-blo...

Status

Unknown

Location

Soon Chun Hyang University Hospital Cheonan

Start Date

2012-02

Trial ID

NCT01736033

Treatments Being Tested

Tamsulosin Finasteride Placebo

CKD-397 Drug-drug Interaction Study (B)

PHASE1

The purpose of this study is to investigate to effect of tadalafil on the p...

Status

Completed

Location

Chonbuk National University Hospital

Start Date

2014-09

Trial ID

NCT02247505

Treatments Being Tested

Harnal-D Cap. 0.2mg Cialis Tab. 5mg

A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia

PHASE1

This study is an open-label, randomized, single dose, multi-stage, cross-ov...

Status

Completed

Location

GSK Investigational Site

Start Date

2011-11-06

Trial ID

NCT01495026

Treatments Being Tested

Dutasteride (0.5mg, fasted state)Dutasteride (0.5mg, fed state)Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fasted state)Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fasted state)Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fasted state)Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fed state)Harnal-D Tablets with water (fasted state)Harnal-D Tablets with water (fed state)Harnal-D tablets without water (fasted state)

Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers

PHASE1

This study is an open-label, randomized, fasted, single dose, crossover stu...

Status

Completed

Location

Bestian Hospital

Start Date

2019-03-11

Trial ID

NCT03887858

Treatments Being Tested

Harnal-D Tab.Chong Kun Dang Tamsulosin HCl Tab.

Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers After Meal

PHASE1

This study is an open-label, randomized, fed, single dose, crossover study ...

Status

Completed

Location

Bestian Hospital

Start Date

2019-03-11

Trial ID

NCT03887871

Treatments Being Tested

Harnal-D Tab.Chong Kun Dang Tamsulosin HCl Tab.

Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males.

PHASE1

This study aims to determine the relative bioavailability of tamsulosin hyd...

Status

Completed

Location

GSK Investigational Site

Start Date

2011-06-30

Trial ID

NCT01471678

Treatments Being Tested

Dutasteride (0.5mg)FDC product of dutasteride (0.5mg) and tamsulosin HCl (0.2mg)Harnal D Tablets and Harnal Capsules (both comprising 0.2 mg tamsulosin HCl)

A Clinical Trial to Evaluate the Effects of Food on the Bioavailability of CKD-397 in Healthy Male Subjects

PHASE1

This study is a randomized, open-label, oral single dosing, two-way crossov...

Status

Completed

Location

Dong-A University Hospital

Start Date

2015-12

Trial ID

NCT02615782

Treatments Being Tested

CKD-397

CKD-397 Drug-drug Interaction Study (A)

PHASE1

The purpose of this study is to investigate to effect of tamsulosin on the ...

Status

Completed

Location

Chonbuk National University Hospital

Start Date

2014-09

Trial ID

NCT02247518

Treatments Being Tested

Cialis Tab. 5mg Harnal-D Cap. 0.2mg

Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and Tamsulosin

PHASE1

The purpose of this study is to investigate the pharmacokinetic drug intera...

Status

Completed

Location

Seoul National University Hospital(SNUH)

Start Date

2014-07

Trial ID

NCT02180997

Treatments Being Tested

Tamsulosin Solifenacin Tamsulosin and solifenacin

Study to Investigate the Efficacy and Safety of GL2702 GLARS-NF1tablet and Harnal-D - Tablet in BPH Patients With LUTS

PHASE3

Study to investigate the efficacy and safety of GL2702 GLARS-NF1tablet and ...

Status

Completed

Location

Eulji general hospital

Start Date

2014-03

Trial ID

NCT02303769

Treatments Being Tested

Tamsulosin HCL 0.4mg Tamsulosin HCL 0.2mg

Previous Next